Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

General

General

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • M&A

Organon Expects Lower EBITDA Margin For FY22, Clocks Mixed Q2 Earnings

By Vandana Singh
August 4, 12:18 PM
Organon & Co’s (NYSE:OGN) Q2 sales decreased 1% Y/Y to $1.59 billion, beating the consensus of $1.54 billion. The sales…

OGN

Read More
2 minute read
  • Biotech
  • General
  • Health Care
  • Long Ideas
  • M&A
  • Movers
  • Small Cap
  • Trading Ideas

ChemoCentryx Shares Are Jumping 110% Thursday: Here’s Why

By Dylan Wechsler
August 4, 12:18 PM
Shares of ChemoCentryx, Inc. (NASDAQ: CCXI) are skyrocketing Thursday following a groundbreaking announcement for the biopharmaceutical company. Why Is It Moving?

AMGN

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • News

Gilead Sciences Bets $400M On Inflammatory Diseases Focused UK Based Firm

By Vandana Singh
August 4, 12:13 PM
Gilead Sciences Inc (NASDAQ:GILD) has agreed to acquire MiroBio, a privately-held U.K.-based biotechnology company focused on restoring immune balance with agonists…

GILD

Read More
2 minute read
  • Biotech
  • Earnings
  • FDA
  • General
  • Guidance
  • Health Care
  • Movers
  • News
  • Trading Ideas

FDA Lifts Clinical Hold On BioCryst’s BCX9930 Program For Rare Blood Disorder

By Vandana Singh
August 4, 12:11 PM
The FDA lifted a partial clinical hold on BioCryst Pharmaceuticals Inc’s (NASDAQ:BCRX) BCX9930 program. The company will resume enrollment under revised protocols…

BCRX

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Penny Stocks

Astria Therapeutics Commences Initial-Stage Skin Disorder Study, Sees Preliminary Data By Year-end

By Ragothaman Srinivasan
August 4, 12:03 PM
Astria Therapeutics (NASDAQ: ATXS) announced initiation of a Phase 1a clinical trial of STAR-0215 in healthy subjects. STAR-0215 is designed to provide long-acting, effective attack prevention for hereditary angioedema (HAE), with dosing once every three months or longer.

ATXS

Read More
1 minute read
  • Commodities
  • General
  • Markets
  • News
  • Politics

OPEC Secretary General Tells Al-Arabiya TV The 100,000 BPD Increase Aims To Test Market Reaction

By Benzinga Newsdesk
August 4, 11:59 AM
-Reuters

USO

Read More
1 minute read
  • Earnings
  • General
  • Guidance
  • News

Read How Penn National Gaming Fared In Q2

By Shivani Kumaresan
August 4, 11:57 AM
Penn National Gaming Inc (NASDAQ:PENN) reported second-quarter FY22 sales growth of 5.2% year-on-year to $1.63 billion, beating the consensus of $1.61…

PENN

Read More
1 minute read
  • General
  • News
  • Politics

President Biden Tweets ‘Putin is still waging his war in Ukraine, putting pressure on global oil supply, and families can feel it. But we stepped up to release one million barrels of oil a day from our Reserve, and rallied our global partners…’

By Benzinga Newsdesk
August 4, 11:54 AM
https://twitter.com/POTUS/status/1555219986498592771

RSX

Read More
1 minute read
  • General
  • News
  • Politics

Congressional Budget Office Says It’s Tough To Say Whether The Us Economy Is In A Recession

By Benzinga Newsdesk
August 4, 11:31 AM
-Bloomberg

SPY

Read More
1 minute read
  • General
  • News
  • Politics

President Biden Weighs Health Emergency Authorities For Monkeypox

By Benzinga Newsdesk
August 4, 11:28 AM
-Politico

AEMD

Posts pagination

Previous 1 … 2,260 2,261 2,262 … 2,367 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service